RT Book, Section
A1 Rosica, Dillenia
A1 Dorbala, Sharmila
A2 Heller, Gary V.
A2 Hendel, Robert C.
SR Print(0)
ID 1145444770
T1 Cardiac Amyloid Imaging and 18F-FDG PET/CT for Imaging Sarcoidosis and Cardiovascular Infection
T2 Nuclear Cardiology: Practical Applications, 3e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259644993
LK accesscardiology.mhmedical.com/content.aspx?aid=1145444770
RD 2024/04/18
AB Cardiac  amyloidosis,  sarcoidosis,  and  cardiovascular  infections  are  major  causes  of  morbidity  and  mortality.  Early  diagnosis  and  timely  application  of  specific  therapy  are  critical  to  improve  clinical  outcomes.1,2  Echocardiography,  cardiac  magnetic  resonance  imaging  (CMR),  and  cardiac  CT  can  detect  increased  wall  thickness,  expanded  extracellular  volume,  diffuse  late  gadolinium  enhancement,  wall  motion  abnormalities,  fibrosis,  vegetations,  and  abscesses  resulting  from  cardiac  amyloidosis,  sarcoidosis,  or  infection.  However,  by  the  time  the  above  cardiac  structural  changes  are  evident,  the  disease  is  at  a  fairly  advanced  stage.  Moreover,  some  of  these  changes  are  nonspecific  and  may  represent  sequelae  of  other  forms  of  heart  diseases  and  are  not  disease  specific.  Radionuclide  imaging  methods  are  evolving  as  specific  disease  markers  in  amyloidosis,  sarcoidosis,  and  infection  imaging.